Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary shows mixed signals: positive growth in defense and electronic systems, but weakness in commercial aerospace and a GAAP EPS loss. The Q&A reveals concerns about destocking and unclear future guidance, but strong bookings and cash flow improvements are positives. Adjusted EPS stability and facility consolidation savings offer some optimism. Overall, the sentiment is balanced, leading to a neutral prediction.
Revenue $212.6 million, a 6% increase year-over-year. Growth driven by a 13% increase in military and space revenue, offset by a 10% decline in commercial aerospace revenue.
Defense Business Growth 13% growth in defense business, with missile franchise up 21%, military fixed-wing aircraft up 17%, and rotary-wing aircraft platforms up 22%. Growth attributed to strong performance in missile and radar platforms.
Commercial Aerospace Revenue Declined 10% year-over-year due to destocking at Boeing and Spirit AeroSystems. However, future outlook is promising with increased build rates for Boeing 737 MAX and 787.
Gross Margins 26.6%, up from 26.2% year-over-year. Improvement due to growing engineered products portfolio, strategic pricing initiatives, restructuring actions, and productivity improvements.
Adjusted Operating Income Margins 10.6%, slightly up from 10.5% year-over-year. Driven by productivity improvements and a profitable business mix in the Structural Systems segment.
Adjusted EBITDA $34.4 million, representing 16.2% of revenue, up $2.5 million from Q3 2024. Improvement attributed to strategic initiatives and operational efficiencies.
Litigation Settlement Costs $99.7 million recorded in Q3 2025 due to the Guaymas Fire litigation settlement. This led to a GAAP EPS loss of $4.30 per share.
Adjusted EPS $0.99 per share, consistent with Q3 2024. Adjusted results exclude litigation settlement costs.
Structural Systems Revenue $89 million, up from $86 million year-over-year. Growth driven by military rotorcraft and ground vehicles, offset by lower revenues in commercial aerospace.
Electronic Systems Revenue $123.1 million, up from $115.4 million year-over-year. Growth driven by missiles, fixed-wing aircraft, and radar systems.
Cash Flow from Operating Activities $18.1 million, up from $13.9 million year-over-year. Improvement due to higher adjusted operating income, lower interest costs, and lower cash taxes.
Engineered Products Revenue: Increased to 23% of total revenue in 2025, up from 15% in 2022, as part of the VISION 2027 strategy.
Apache Tail Rotor Blade: Fully approved by Boeing and in production at the new Coxsackie, New York location.
Missile Programs: Strong growth with 21% increase in Q3 2025, driven by platforms like Tomahawk, AMRAAM, and Naval Strike Missile.
Defense Business Growth: Achieved 13% growth in Q3 2025, with strong performance in missiles, fixed-wing aircraft, and radar systems.
Commercial Aerospace Outlook: Despite a 10% decline in Q3 2025, Boeing's FAA approval to increase 737 MAX build rates and 787 production provides optimism for 2026.
Facility Consolidation: Completed transitions of key programs to lower-cost facilities, including Guaymas, Mexico, and Coxsackie, New York, with expected annual savings of $11-$13 million by 2026.
Adjusted EBITDA: Achieved record levels of 16.2% of revenue in Q3 2025, progressing towards the VISION 2027 goal of 18%.
VISION 2027 Strategy: Focus on increasing engineered product revenue, consolidating facilities, and expanding defense and commercial aerospace content.
Litigation Settlement: Resolved Guaymas Fire litigation with a $150 million settlement, partially funded by insurance.
Cyclicality of end-use markets: The company's performance is subject to the cyclicality of its end-use markets, which could lead to fluctuations in demand and revenue.
U.S. government defense spending: The level of U.S. government defense spending poses a risk, as changes in budget allocations could impact the company's defense-related revenues.
Customer delays in product launches: Delays in the launch and certification of new products by customers could negatively affect the company's revenue and operational timelines.
Financing and debt servicing: The company's ability to obtain financing and service existing debt is critical to funding capital expenditures and meeting working capital needs.
Legal and regulatory risks: Pending litigation matters, including the Guaymas Performance Center fire, could result in material financial losses.
Cost of expansion and acquisitions: The cost associated with expansion, consolidation, and acquisitions could strain financial resources and impact profitability.
Competition: Competitive pressures in the market could affect the company's ability to maintain or grow its market share.
Economic and geopolitical developments: Supply chain issues, international trade restrictions, tariffs, and elevated interest rates pose risks to operations and financial performance.
U.S. federal government shutdown: A prolonged U.S. federal government shutdown could disrupt operations and delay contracts.
Labor and personnel risks: Challenges in attracting and retaining key personnel, as well as potential labor disruptions, could impact operations.
Intellectual property risks: Inadequate protection and enforcement of intellectual property rights could harm the company's competitive position.
Cybersecurity risks: The risk of cybersecurity attacks could disrupt operations and compromise sensitive data.
Commercial aerospace headwinds: The commercial aerospace business faces headwinds, including destocking at major customers like Boeing and Spirit AeroSystems, leading to a 10% revenue decline in the quarter.
Guaymas fire litigation settlement: The company incurred a $150 million settlement cost related to the Guaymas fire litigation, impacting financial results.
Facility consolidation challenges: The ongoing restructuring and facility consolidation initiatives could face execution risks, potentially delaying cost savings and operational efficiencies.
Revenue Growth: The company reaffirms its guidance of mid-single-digit revenue growth for the full year 2025 and expects low double-digit growth in Q4 2025.
Defense Business Outlook: Continued momentum is expected in the defense business, driven by strong performance in missile and radar platforms. The company anticipates benefiting from replenishment of depleted worldwide inventories and robust U.S. and FMS order activity.
Commercial Aerospace Outlook: The commercial aerospace segment is expected to recover in 2026 as Boeing increases production rates for the 737 MAX and 787 platforms. Destocking is anticipated to continue impacting this segment in the near term.
VISION 2027 Goals: The company is on track to achieve its VISION 2027 goal of 18% adjusted EBITDA margin, with progress shown by achieving 16.2% in Q3 2025. The target of 25% engineered product revenues is also within reach, with 23% achieved year-to-date.
Facility Consolidation Savings: The ongoing facility consolidation initiative is expected to generate $11 million to $13 million in annual savings by 2026, with synergies ramping up as production increases at consolidated facilities.
Liquidity and Capital Resources: The company plans to draw down $95 million in Q4 2025 to settle legal obligations, leaving sufficient liquidity for operations and acquisitions. Pro forma net leverage is expected to be approximately 2.3x after the drawdown.
The selected topic was not discussed during the call.
The earnings call summary shows mixed signals: positive growth in defense and electronic systems, but weakness in commercial aerospace and a GAAP EPS loss. The Q&A reveals concerns about destocking and unclear future guidance, but strong bookings and cash flow improvements are positives. Adjusted EPS stability and facility consolidation savings offer some optimism. Overall, the sentiment is balanced, leading to a neutral prediction.
The earnings call reveals mixed results: strong defense revenue growth and improved margins are positive, but the decline in commercial aerospace and industrial revenues, along with a decrease in backlog, are concerning. The Q&A highlights ongoing destocking issues and management's uncertainty regarding its resolution. Despite strong cash flow and potential future growth, the lack of clear guidance on key issues tempers optimism. Thus, the overall sentiment is neutral, with no strong catalyst to drive significant stock price movement.
The earnings call shows a generally positive outlook with strong financial performance, including revenue and margin growth, and optimistic guidance for defense and engineered products. The Q&A section reveals some uncertainties, particularly in commercial aerospace growth and M&A timing, but these are outweighed by positive indicators like improved EPS, backlog, and strategic focus on high-margin products. The absence of a shareholder return plan is neutral, but overall, the positive financial metrics and strategic initiatives suggest a likely stock price increase of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.